XTalks

JUNE 9, 2023

Consistency is a key factor in any successful life science content marketing strategy. By keeping the conversation going, content marketers within the life science industry can build trust with their audience and create a loyal following that will continue to engage with their content and products over time.

Life Science 98

Life Science Marketing Branding Production 98

Pharmaceutical Technology

SEPTEMBER 15, 2022

From the Human Genome Project to contemporary drug development, collaboration is critical to the life sciences. It is also an important factor in the success of life sciences clusters, where a high concentration of pharmaceutical or medical device companies can all be found in one district, city or region.

Life Science 130

Life Science Drug Delivery Genome Project Development 130

Pharmaceutical Technology

AUGUST 15, 2022

It is no secret that Canada boasts a strong and competitive life sciences sector. Within Canada, one province has often stood out as the place to be for cutting-edge life sciences innovation. These factors have combined to make Ontario a leading force for medical research and innovation. Again, this is nothing new.

Life Science 130

Life Science Research Manufacturing Insulin 130

XTalks

JULY 14, 2022

There is no doubt that business-to-business (B2B) life science webinars allow you to connect with potential and current customers in a very personal way. There are certainly a lot of benefits that can come with using this medium, so why not perfect your webinar marketing campaign with professional webinar production services?

Life Science 98

Life Science Production Marketing Branding 98

pharmaphorum

JANUARY 6, 2023

From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables life sciences teams to collaborate efficiently and effectively in 2023. He is responsible for customer engagement, market adoption, and strategic alliances.

Life Science 111

Life Science Development Research Production 111

pharmaphorum

JANUARY 29, 2021

The future of life sciences CRM will be defined by rapid digital transformation and a focus on customer experience – and those who stick to old ways of working will be left in the dust, according to new research from Gartner. From CRM to CXM.

Life Science 126

Life Science Sales Marketing Pharma Companies 126

XTalks

DECEMBER 20, 2023

As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables. These companies are at various stages of research and clinical trials.

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

XTalks

FEBRUARY 14, 2023

The life science industry is constantly evolving, making it difficult to stay ahead of the curve. There’s no doubt that pharmaceutical and biotechnology organizations are utilizing innovative technology solutions across all sectors of drug development, research and development, supply chain, manufacturing and more.

Life Science 98

Life Science Clinical Trials Clinical Trials Development 98

XTalks

APRIL 7, 2025

Optum Life Sciences expert provides insights on the latest trends. For manufacturers developing GLP-1s or in the market, its invaluable to understand the nuances of how real-world evidence (RWE) can be harnessed to demonstrate the clinical and economic value of weight loss medications.

Life Science 52

Life Science Research Trials Manufacturing 52

Cloudbyz

MAY 17, 2024

This Act is poised to significantly change the clinical trials landscape within the life sciences sector. As AI increasingly becomes a cornerstone in clinical research and drug development, it is crucial for industry stakeholders to grasp the extensive implications of this regulation. first appeared on CLOUDBYZ.

Life Science 102

Life Science Clinical Trials Clinical Trials Trials 102

XTalks

JUNE 21, 2022

WhizAI brings an augmented consumer platform to the life sciences industry to deliver better, smarter and faster business decisions at lower TCO with contextual, AI-powered analytics. Last year, Gartner Research published a report titled “Top Trends in Data and Analytics for 2021: The Rise of the Augmented Consumer.”

Life Science 105

Life Science Sales Marketing Manufacturing 105

XTalks

SEPTEMBER 29, 2021

Life science workers are one of the most common areas of work that could not eliminate all visits to the office or lab during the COVID-19 pandemic. Some scientists and researchers have been visiting their workplaces during the pandemic. So, what will work look like in the life sciences as we emerge from the pandemic?

Life Science 122

Life Science HR Scientist Genetic Disease 122

Cloudbyz

MARCH 17, 2024

In the dynamic world of life sciences, where innovation is paramount, the integration of cutting-edge technologies is crucial for accelerating clinical operations and driving breakthroughs in healthcare. Salesforce’s recent announcement of its Life Sciences Cloud marks a significant stride towards this goal.

Life Science 81

Life Science Clinical Trials Clinical Trials Trials 81

XTalks

JULY 5, 2023

Established in 2018, CytoMed is a biotechnology firm that originated from the Agency for Science, Technology and Research (A*STAR), Singapore’s premier public sector research and development agency. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 97

Life Science Development Engineer Scientist 97

pharmaphorum

OCTOBER 28, 2022

In the early stages of drug development, it is logical to focus on the economic and clinical aspects of candidate identification: Is there enough of a market? This is an important effort, but as with any traditional market research, it focuses on needs that the target audience has already identified.

Life Science 105

Life Science Production Development Drugs 105

World of DTC Marketing

JANUARY 24, 2022

The amount of money required to gain approval of a new drug has been hotly debated, but it also costs a hell of a lot of money to launch a drug in today’s market. A study in 2020 estimated that the median cost of getting a new drug into the market was $985 million, and the average price was $1.3 Only about $2.2 Only about $2.2

Life Science 225

Life Science Drugs Development Genetic Disease 225

World of DTC Marketing

MARCH 3, 2022

Successful, forward-thinking brands take a digital- and consumer-first approach to marketing across ages and populations. 90% want physician directories available on life sciences and pharmaceutical sites. The post More bad research on pharma websites appeared first on World of DTC Marketing.com.

Research 143

Research Branding Doctors Doctor 143

pharmaphorum

JANUARY 10, 2023

Data is transforming life sciences, but many organisations are not using its full potential. Life sciences and the pharmaceutical industry are awash with data. Capturing market share. The combination of health and data, he passionately believes, will transform life sciences. billion in 2021 to $9.23

Marketing 98

Marketing Life Science Sales Branding 98

BioPharma Reporter

JULY 23, 2024

As a strategic brand consultant at ramarketing, Laura combines her extensive background in clinical research with strategic leadership and creative expression.

Life Science 95

Life Science Branding Clinical Research Research 95

XTalks

MARCH 26, 2025

In the fast-evolving field of clinical research, thought leaders do more than just keep up; they lead the charge and shape the direction of the industry. Heres how thought leaders are currently making an impact in clinical research: 1.

Clinical Research 52

Clinical Research Research Branding Clinical Trials 52

pharmaphorum

DECEMBER 23, 2022

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). Given the demand to deliver a steady stream of content to meet HCPs’ needs, pharma marketers must react, create, edit, and adapt quickly. And in 2023, these investments will hopefully pay off.

Sales 105

Sales Marketing Life Science Compliance 105

XTalks

JANUARY 7, 2025

These strategic deals have reshaped the competitive landscape, spurred innovation and enabled companies to diversify their product offerings, expand into new markets and enhance operational efficiencies. The deal was valued at approximately $25 billion and strengthened Abbotts presence in the cardiovascular devices market.

Life Science 105

Life Science Manufacturing Production Clinical Development 105

pharmaphorum

MAY 24, 2022

Organisations are missing out on the ability to harness their data to energise precision marketing and transform commercial performance. The pharma industry is adjusting to massive upheaval from the pandemic and markets are emerging from its grip reshaped and alive with competition. Deeper Insights. Deeper Insights.

Marketing 111

Marketing Sales Life Science Pharma Companies 111

Pharmaceutical Technology

MARCH 10, 2023

In the past, researchers have often had to seek help from outside the UK, thus delaying clinical trials and patient access. The NHSBT hopes the CBC will increase the UK’s competitiveness within the market. The opening of this new facility plays into the UK government’s Life Sciences Industrial Strategy.

Gene Therapy 264

Gene Therapy Manufacturing Gene Clinical Trials 264

pharmaphorum

FEBRUARY 24, 2022

The UK’s health research data capabilities are rapidly evolving. For example, during the height of the pandemic, NIHR’s integrated health research system was able to compare COVID-19 hospital caseloads to COVID-19 research activity in real time. How this data can help with research planning, recruitment, and engagement.

Clinical Research 105

Clinical Research Research Life Science Clinical Trials 105

XTalks

OCTOBER 17, 2022

In this interview, Craig Lipset, Co-Founder of the Decentralized Trials & Research Alliance, discusses the Alliance’s new glossary for industry and more. The global virtual clinical trials market is valued at $8.3 Today organizations have been stabilizing their approaches for decentralized research. percent to reach $12.9

Trials 98

Trials Research Clinical Trials Clinical Trials 98

XTalks

JANUARY 20, 2025

Among these, mergers and acquisitions (M&As) have played a pivotal role in reshaping the industry landscape, enabling companies to bolster their portfolios, enhance R&D capabilities and expand their global market reach.

Marketing 104

Marketing Botox Life Science Pharma Companies 104

XTalks

MARCH 26, 2025

Let’s explore some of the innovative research and emerging trends shaping the epilepsy treatment landscape in this blog. Exploring Innovation in Epilepsy on Purple Day 2025 The progress seen in epilepsy research over recent years is nothing short of inspiring. Imaging and biomarker research are improving diagnostic precision.

Life Science 66

Life Science Gene Expression Trials Drugs 66

XTalks

MARCH 12, 2025

Following the success of Issue 3 , which focused on the critical importance of patient diversity in clinical research, Xtalks is thrilled to announce Xtalks Clinical Edge Issue 4. These prominent leaders will share their experiences, strategies and visions about whats next for clinical research.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

Cloudbyz

DECEMBER 22, 2024

This achievement solidifies Cloudbyzs position as a trusted partner in advancing clinical research through cutting-edge, cloud-based technologies. Why This Recognition Matters The Everest Group PEAK Matrix serves as an industry benchmark, evaluating technology providers based on market impact, vision, and capability.

Compliance 52

Compliance Clinical Trials Clinical Trials Life Science 52

pharmaphorum

MARCH 23, 2022

Four out of five biopharma companies think that the market opportunity for connected health products exceeds their traditional drug business, but adoption remains low, with only 20% of use cases at present going beyond proof of concept.

Life Science 124

Life Science Production Marketing Development 124

Cloudbyz

OCTOBER 25, 2023

Naperville, Illinois – October 24, 2023 : Cloudbyz, an innovative digital clinical research solutions provider, today announced a new partnership with SPAR Solutions who provide a complete range of customer engagement solutions covering sales, marketing, service, and communities.

Life Science 104

Life Science Clinical Trials Clinical Trials Compliance 104

pharmaphorum

JULY 27, 2022

Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Despite the UK’s potential as an international life sciences leader, it lags many competitors in a number of key metrics, including access to new medicines and global share of clinical trial recruitment.

Life Science 98

Life Science Clinical Trials Clinical Trials Medicine 98

XTalks

JANUARY 16, 2025

million diagnosed cases of Parkinsons disease in the major markets, with the US accounting for about 45% of these cases. This year has started strong for Parkinsons disease research with progress in several clinical trials and medical devices. As of 2023, there were approximately 2.7

Trials 104

Trials Clinical Trials Clinical Trials Gene Therapy 104

pharmaphorum

JANUARY 25, 2021

The clinical research community has been disrupted in a number of ways due to COVID-19 and sparked a spirit of collaboration and innovation. Worldwide Clinical Trial’s Aman Khera gives five predictions of how clinical research could change in 2021. It goes without saying, but paper-based patient data collection is archaic.

Clinical Research 124

Clinical Research Research Clinical Trials Clinical Trials 124

Velocity Clinical Research

MARCH 23, 2025

The UK life sciences industry is clearly in need of support. Initially, three-quarters of the funding was earmarked for establishing 18 Commercial Research Delivery Centres (CRDCs). They provide faster access to new treatments and the chance to contribute to life-changing research.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

pharmaphorum

OCTOBER 28, 2022

Angela is working to ensure the UK life sciences sector expands its footprint as a priority country for inward investment in research and medicines launch as healthcare ecosystems recover from the impact of COVID-19. She is an SME in market access, rare disease and biosimilars.

Medicine 122

Medicine Life Science Marketing Clinical Trials 122